Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,639 | -53,533 | -8,193 | -61,217 | -62,478 |
| Depreciation Amortization | 1,566 | 2,158 | 5,510 | 47,839 | 5,438 |
| Accounts receivable | 1,866 | 56,065 | -14,791 | -4,429 | N/A |
| Accounts payable and accrued liabilities | -1,092 | -1,094 | -4,213 | -8,073 | N/A |
| Other Working Capital | -11,601 | 42,377 | -34,732 | -13,172 | -11,694 |
| Other Operating Activity | 5,214 | -53,435 | 21,182 | 18,872 | -426 |
| Operating Cash Flow | $-59,687 | $-7,462 | $-35,238 | $-20,181 | $-69,161 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,959 | 10,377 | N/A | N/A | N/A |
| PPE Investments | -158 | -423 | -218 | -564 | -1,091 |
| Sale Of Investment | N/A | N/A | 24,642 | 3,161 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -2,165 | -619 | -474 |
| Other Investing Activity | 446 | 1 | -2,095 | -620 | 6 |
| Investing Cash Flow | $8,247 | $9,955 | $22,329 | $1,978 | $-1,085 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 33,955 |
| Debt Repayment | -10,082 | -9,670 | -2,555 | -2,135 | -2,448 |
| Common Stock Issued | 16,950 | 3,168 | 428 | 209 | 590 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -369 |
| Financing Cash Flow | $6,868 | $-6,501 | $-2,128 | $-1,926 | $31,728 |
| Exchange Rate Effect | 1,236 | -547 | 297 | -451 | -571 |
| Beginning Cash Position | 75,120 | 76,402 | 91,157 | 109,317 | 161,839 |
| End Cash Position | 31,783 | 71,847 | 76,416 | 88,740 | 122,754 |
| Net Cash Flow | $-43,337 | $-4,555 | $-14,741 | $-20,578 | $-39,086 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,687 | -7,462 | -35,238 | -20,181 | -69,161 |
| Capital Expenditure | -158 | -423 | -380 | -564 | -1,099 |
| Free Cash Flow | -59,845 | -7,885 | -35,617 | -20,744 | -70,260 |